tri(p-tolyl)amine,
tri-p-tolylamine,
Tri-p-tolylamine,
1159-53-1,
4,4',4''-Trimethyltriphenylamine,
4,4,4-Trimethyltriphenylamine,
Benzenamine, 4-methyl-N,N-bis(4-methylphenyl)-,
tri(p-tolyl)amine,
trip-tolylamine,
tris(4-methylphenyl)amine,
N,N-Di-p-tolyl-p-toluidine,
4-methyl-N,N-bis(4-methylphenyl)aniline,
MFCD00674043,
N,N,N-tri(p-tolyl)amine,
W-108588,
EINECS 214-595-1,
Tri-p-tolylamine, 97%,
A2380,
ACMC-2099rh,
AC1L2F1Y,
AC1Q1IS8,
SCHEMBL76680,
KSC509K7F,
Jsp001145,
2,4,4'-Trimethyltriphenylamine,
DTXSID6061573,
CTK4A9572,
KS-00000VDC,
YXYUIABODWXVIK-UHFFFAOYSA-,
YXYUIABODWXVIK-UHFFFAOYSA-N,
4-methyl-N,N-bis(p-tolyl)aniline,
ACN-S002627,
ZINC2568263,
4,4',4''-Trimethyl triphenylamine,
ANW-16923,
AKOS015889790,
MCULE-7424667347,
RTC-010801,
4,4\',4\'\'-Trimethyltriphenylamine,
AJ-41596,
AK-96668,
AN-48744,
CJ-09848,
OR315379,
P846,
SC-98880,
SY037083,
AB1010270,
AX8001354,
4CH-023839,
FT-0633417,
ST24050235,
ST50319729,
MFCD00674043 (97%),
22919-EP2276085A1,
22919-EP2315502A1,
159T531,
C-18096,
I01-3053,
InChI=1/C21H21N/c1-16-4-10-19(11-5-16)22(20-12-6-17(2)7-13-20)21-14-8-18(3)9-15-21/h4-15H,1-3H3,
C21H21N,
CID70873,
AR-1L7036,
C21-H21-N,
ACN-029603,
Tri-p-tolylamine, 98% - 25G 25g,
T2558,
Anti-Influenza A Virus Neuraminidase N2 Monoclonal Antibody,
117-74-8,